Grey Literature International Steering Committee

CBAS and WAYS Invite Applications for the World Association of Young Scientists Sustainable Development Goals Award

Retrieved on: 
Thursday, September 14, 2023
Science, Partnership, SDG, World Association of Young Scientists, United Nations, China Association for Science and Technology, Research fellow, Breeding, City, Global Facility for Disaster Reduction and Recovery, Life, International Patient Safety Goals, Research, Callum Roberts (footballer), Sustainable Development Goals, Drinking, Grey Literature International Steering Committee, International Science Council, Organization, Global Young Academy, Wenzhou, Green affordable housing, Climate change, Wenzhou Medical University, Engineering, Community, International Year of Basic Sciences for Sustainable Development, Climate change mitigation, International Research Center for Traditional Polyphony, United Nations Development Programme, Ageing, Sustainable development, Water resources, RMB, WAYS, Tourism, Transport, Sanitation

BEIJING, Sept. 14, 2023 /PRNewswire/ -- In response to the pressing global challenges of sustainable development, the World Association of Young Scientists (WAYS), in collaboration with the International Research Center of Big Data for Sustainable Development Goals (CBAS) is proud to announce the prestigious World Association of Young Scientists Sustainable Development Goals Award (WAYS SDG Award).

Key Points: 
  • BEIJING, Sept. 14, 2023 /PRNewswire/ -- In response to the pressing global challenges of sustainable development, the World Association of Young Scientists (WAYS), in collaboration with the International Research Center of Big Data for Sustainable Development Goals (CBAS) is proud to announce the prestigious World Association of Young Scientists Sustainable Development Goals Award (WAYS SDG Award).
  • This prestigious award aims to celebrate and support young scientists who have made significant contributions to advancing sustainable development goals (SDGs) through their innovative basic and applied science research and engineering endeavors.
  • The WAYS SDG Award is made possible with the sponsorship of the China Association for Science and Technology and the Wenzhou World Young Scientist Growth Foundation.
  • Individuals and organizations are encouraged to join in recognizing and celebrating the remarkable contributions of young scientists who are propelling sustainable development and shaping a brighter future for all.

The Support Club Acknowledges the Broad Opposition Demonstrated Amongst Unsecured Creditors to Orpea’s Accelerated Safeguard Plan and Notes the Voting Process to Be an Additional Irregularity That Renders the Whole Plan Unlawful

Retrieved on: 
Thursday, June 29, 2023
Professional Services, Finance, Grey Literature International Steering Committee, Court of Appeals of Virginia, Bytown Boys Supporters Club, Administrator, Federal Judicial Administration Council, Outlaw, Commercial code, CDC, Committee, Letter, Support, Economics, Security (finance), Palace of Versailles

The Support Club acknowledges the broad opposition demonstrated amongst unsecured creditors by the holders of Class 8 claims, Class 7 claims and Class 7bis claims to Orpea’s accelerated safeguard plan and notes the voting process to be an additional irregularity that renders the whole plan unlawful.

Key Points: 
  • The Support Club acknowledges the broad opposition demonstrated amongst unsecured creditors by the holders of Class 8 claims, Class 7 claims and Class 7bis claims to Orpea’s accelerated safeguard plan and notes the voting process to be an additional irregularity that renders the whole plan unlawful.
  • The Support Club continues to believe the current restructuring plan arbitrarily favors and enriches the French State’s investment vehicle, Caisse des dépôts et consignations (the CDC), the Steering Committee and certain (primarily French) creditors.
  • This development is even more concerning for unsecured creditors invested in France, with the Orpea restructuring process continuing to set a terrible precedent.
  • We note that some other distressed unsecured claims in France have plummeted in value since the recent developments in Orpea.

Johnson Controls' Katie McGinty named top 50 sustainable business leader

Retrieved on: 
Thursday, May 11, 2023
Constellation, Science, Most, Corporate America, Carbon accounting, Science Based Targets initiative, Muhlenberg College, Optimism, Partnership, Internet of things, Grey Literature International Steering Committee, Platinum, Intelligence, Energy, American Council, Finance, American Council on Renewable Energy, History, McGinty, Corporate Knights, JCI, Organization, Johnson Controls, Carnegie Mellon University, AAA, Responsibility, CDP, Dickinson College, World Sustainable Development Summit, ESG, Environment, AI, Research, NYSE, CORK, Knight, Pharmaceutical industry, Management, Renewable energy, MSCI, Sustainalytics, Woman

Johnson Controls is creating and deploying technology – the smart building trifecta of energy-efficient equipment, clean electrification and systemic digitalization – to accelerate its own net zero journey.

Key Points: 
  • Johnson Controls is creating and deploying technology – the smart building trifecta of energy-efficient equipment, clean electrification and systemic digitalization – to accelerate its own net zero journey.
  • CDP , Corporate Knights , and the Financial T imes have distinguished Johnson Controls as a climate leader.
  • Johnson Controls has an AAA rating from MSCI and was named to the Clean200 for its high proportion of sustainable revenue.
  • 3BL named Johnson Controls one of the 100 Best Corporate Citizens , and the company was named to Fortune's Change the World list.

Johnson Controls' Katie McGinty named top 50 sustainable business leader

Retrieved on: 
Thursday, May 11, 2023
Constellation, Science, Most, Corporate America, Carbon accounting, Science Based Targets initiative, Muhlenberg College, Optimism, Partnership, Internet of things, Grey Literature International Steering Committee, Platinum, Intelligence, Energy, American Council, Finance, American Council on Renewable Energy, History, McGinty, Corporate Knights, JCI, Organization, Johnson Controls, Carnegie Mellon University, AAA, Responsibility, CDP, Dickinson College, World Sustainable Development Summit, ESG, Environment, AI, Research, NYSE, CORK, Knight, Pharmaceutical industry, Management, Renewable energy, MSCI, Sustainalytics, Woman

Johnson Controls is creating and deploying technology – the smart building trifecta of energy-efficient equipment, clean electrification and systemic digitalization – to accelerate its own net zero journey.

Key Points: 
  • Johnson Controls is creating and deploying technology – the smart building trifecta of energy-efficient equipment, clean electrification and systemic digitalization – to accelerate its own net zero journey.
  • CDP , Corporate Knights , and the Financial T imes have distinguished Johnson Controls as a climate leader.
  • Johnson Controls has an AAA rating from MSCI and was named to the Clean200 for its high proportion of sustainable revenue.
  • 3BL named Johnson Controls one of the 100 Best Corporate Citizens , and the company was named to Fortune's Change the World list.

EQS-News: Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis

Retrieved on: 
Monday, April 17, 2023
Grey Literature International Steering Committee, Therapy, Icahn School of Medicine at Mount Sinai, Gastroenterology, Mount Sinai, CMO, Ulcerative colitis, Euronext Paris, Committee, UC, Patient, CEST, Immune system, Mount Sinai Health System, ITT, Disease, Safety, Pharmaceutical industry, Medicine, Abivax

These data emphasize obefazimod’s potential to maintain and further improve patient outcomes over time, as well as its safety and tolerability profile suitable for chronic use.

Key Points: 
  • These data emphasize obefazimod’s potential to maintain and further improve patient outcomes over time, as well as its safety and tolerability profile suitable for chronic use.
  • Moreover, obefazimod also continues to show excellent safety and is well-tolerated by patients, which is important for its chronic, once-daily use.
  • I am optimistic that the ongoing Phase 3 program with obefazimod in UC will confirm these very encouraging data.
  • The final analysis after two years of treatment from the Phase 2b open-label extension study in UC included the intent-to-treat population (ITT) of 217 patients who enrolled into the maintenance study with 50mg obefazimod once-daily oral:

MARAbio Systems, Inc. Appoints Dr. Michael Paul to Serve as Company's Chief Executive Officer

Retrieved on: 
Monday, April 17, 2023
Transfer, MIND, Grey Literature International Steering Committee, Business development, Vice, Pregnancy, University of California, Davis, University, Therapy, Business, Woman, SALT, Lineagen, MARA, Organization, Biochemistry, Incidence, Molecular biology, Shire (pharmaceutical company), Committee, Ernst & Young Entrepreneur of the Year Award, Acquisition, UC, Physician, Risk, Child, Medicine, Spectrum, FDA, Autoantibody, Medical device, Vaccine, Birth control, Pharmaceutical industry, Health care

SALT LAKE CITY, April 17, 2023 /PRNewswire/ -- MARAbio Systems (MARAbio), a precision medicine biotechnology company, has appointed Dr. Michael Paul to serve as the company's CEO. Dr. Paul has more than 25 years of life-sciences industry experience, including leading a number of organizations from formation to strategic exit. MARAbio's technology enables the earliest detection for risk of developing a specific subtype of autism through a simple blood test in the mother, either prior to pregnancy or after the child is born. Dr. Paul succeeds Dr. James Woody, who will continue to serve as Vice Chairman of the Board of Directors.

Key Points: 
  • SALT LAKE CITY, April 17, 2023 /PRNewswire/ -- MARAbio Systems (MARAbio), a precision medicine biotechnology company, has appointed Dr. Michael Paul to serve as the company's CEO.
  • Dr. Paul has more than 25 years of life-sciences industry experience, including leading a number of organizations from formation to strategic exit.
  • Dr. Paul succeeds Dr. James Woody, who will continue to serve as Vice Chairman of the Board of Directors.
  • Dr. Paul is Chief Executive Officer for MARAbio.

HealthTrust Spotlights the Release of Industry Annual Report

Retrieved on: 
Thursday, March 16, 2023
Physical Therapy, Mental Health, Surgery, Managed Care, Medical Devices, General Health, Professional Services, Hospitals, Nursing, Medical Supplies, Cardiology, Health, Other Health, Other Professional Services, Pharmaceutical, Practice Management, Consulting, Grey Literature International Steering Committee, General counsel, Information technology, Strategic sourcing, Initiative, Organization, Committee, Ethics, Chief, GPO, Management

HealthTrust Performance GroupSM , a leading healthcare performance improvement company, supports ethical business standards and conduct in the healthcare supply chain as espoused in the 17th Annual Report of the Healthcare Group Purchasing Industry Initiative , or HGPII.

Key Points: 
  • HealthTrust Performance GroupSM , a leading healthcare performance improvement company, supports ethical business standards and conduct in the healthcare supply chain as espoused in the 17th Annual Report of the Healthcare Group Purchasing Industry Initiative , or HGPII.
  • HealthTrust also announced that Guy Wagner, Vice President of Strategic Sourcing, Commercial Products, will serve as Steering Committee Chair of HGPII.
  • As a founding and active member of HGPII, HealthTrust is contributing to a more resilient healthcare supply chain while adhering to industry commitments to advance product quality and cost savings for health systems.
  • “HealthTrust is proud to be a member of HGPII and embraces its high ethical values,” said Jones.

Greenwich LifeSciences Provides Year End Update

Retrieved on: 
Thursday, December 29, 2022
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Cancer, David Geffen School of Medicine at UCLA, Baylor College of Medicine, Baylor University Medical Center, Texas Oncology, Department of Medicine – University of Pamplona, Grey Literature International Steering Committee, Dan, Woman, Immunotherapy, Patient, Northwestern University, Baylor University, Committee, Santa Claus, UCLA, HER2, Feinberg School of Medicine, Hematology, GP2, Management, Medical imaging, Pharmaceutical industry, McKesson Corporation, Medicine, Breast cancer

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today provided the following year end update.

Key Points: 
  • Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today provided the following year end update.
  • We believe that GP2 carries great potential to improve outcomes for patients with HER2 positive breast cancer.
  • The Company has added a new page to its website to provide updates to Flamingo-01 which includes a map of participating clinical sites in the US (view here ).
  • The current listing of US sites from www.clinicaltrials.gov with email contact information for some sites is also shown below and will be continually updated during the trial:

NCAA DIVISION II MANAGEMENT COUNCIL ADDS FLORIDA SOUTHERN COLLEGE'S DR. KATHERINE LOH

Retrieved on: 
Wednesday, November 9, 2022
School, News, Technology Business Management Council, 2008 NCAA Division I baseball season, The Princeton Review, Sunshine State Conference, Growth, Dean, Advisory Committee, Diversity, Knowledge, Council, Education, Sunlight, U.S. News & World Report, Communication, FAR, Business, Student, Learning, Committee, View, 2018 World Lacrosse Championship, Division II, Conference, Athlete, Grey Literature International Steering Committee, NCAA, AACSB, FSC, Division, John Clarke (dean of Wells), Research, Multimedia, Outline of health sciences, College, Medical device, Medicine, Management, Nursing, Athletics, Florida Southern College, Fortune

LAKELAND, Fla., Nov. 9, 2022 /PRNewswire/ -- Florida Southern College's Dr. Katherine Loh has been selected to serve on the NCAA Division II Management Council.

Key Points: 
  • LAKELAND, Fla., Nov. 9, 2022 /PRNewswire/ -- Florida Southern College's Dr. Katherine Loh has been selected to serve on the NCAA Division II Management Council.
  • Loh, who serves as FSC's Faculty Athletics Representative (FAR), is the first member named to the NCAA DII Management Council from Florida Southern and is the eighth from the Sunshine State Conference.
  • "I am proud of Dr. Loh and appreciate her hard work and determination to support Division II athletics," said Dr. Anne B. Kerr, President of Florida Southern College.
  • Florida Southern has a 14:1 student-to-faculty ratio, is an award-winning national leader in engaged learning, and boasts 30 NCAA Division II National Championships.

New Analysis of SCORED Trial Demonstrates Sotagliflozin’s Effect on Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease

Retrieved on: 
Saturday, November 5, 2022
Patient, American Heart Association, Annual report, Protein, Research, Gastrointestinal tract, Type 2 diabetes, Growth, Committee, Society, SGLT2, Death, University, GLOBE, Form 10-K, Grey Literature International Steering Committee, Chronic kidney disease, SGLT1, Intellectual property, Heart failure, Department of Medicine – University of Pamplona, Neuropathic pain, Department, EGFR, Poster, Nasdaq, Albuminuria, ASN, U.S. Securities and Exchange Commission, Cardiovascular disease, Risk, Metabolism, The New England Journal of Medicine, Diabetes, Disease, Security (finance), AHA, Gene, Kidney, NEJM, Pharmaceutical industry, Lexicon

THE WOODLANDS, Texas, Nov. 05, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that a new post hoc analysis of results from the SCORED Phase 3 outcomes trial of sotagliflozin, an investigational dual SGLT1 and SGLT2 inhibitor, was presented at the American Society of Nephrology Kidney Week 2022 annual scientific meeting in Orlando, Florida.

Key Points: 
  • Sotagliflozin showed statistically significant reductions in UACR regardless of albuminuria status at baseline in the SCORED trial, said David Z.I.
  • D., Professor in the Department of Medicine at the University of Toronto, and a member of the Steering Committee for the SCORED trial.
  • The poster, Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease, can be downloaded from the ASN website .
  • The presence of albuminuria in patients with or without diabetes is associated with an increased risk for adverse renal and cardiovascular outcomes.